Clinical Trial Update: First in Human Study of QLS5316 in Solid Tumors [Phase 1]

View source ↗

Summary

This is a first-in-human Phase 1 trial of QLS5316 in various solid tumors; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• QLS5316 (QLS5316)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Solid Tumors, Colorectal Cancer | Phase 1 | Status: NOT_YET_RECRUITING